Abbvie Inc Drug Patent Portfolio

Abbvie Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abbvie Inc News

AbbVie Partners with TrumpRx for Tariff Relief and Greater Pricing Flexibility

14 Jan, 2026

Editorial | An Easy Approach to Reduce Prescription Medication Costs in the United States – MIR

11 Jan, 2026

Anticipations for AbbVie's Immunology Division in the Fourth Quarter - TradingView

09 Jan, 2026

Anticipations for AbbVie's Immunology Division in the Fourth Quarter

09 Jan, 2026

See More